Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 USD | +6.56% | +3.72% | -1.52% |
Financials (USD)
Sales 2024 * | 23.11M | Sales 2025 * | 18.17M | Capitalization | 159M |
---|---|---|---|---|---|
Net income 2024 * | -37M | Net income 2025 * | -33M | EV / Sales 2024 * | 6.89 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 8.76 x |
P/E ratio 2024 * |
-4.52
x | P/E ratio 2025 * |
-4.37
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.34% |
Latest transcript on ProQR Therapeutics N.V.
1 day | +6.56% | ||
1 week | +3.72% | ||
1 month | +0.52% | ||
3 months | -3.23% | ||
6 months | +25.81% | ||
Current year | -1.52% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel de Boer
FOU | Founder | 41 | 12-02-20 |
Founder | 60 | 12-02-20 | |
Jurriaan Dekkers
DFI | Director of Finance/CFO | - | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Domenico Valerio
FOU | Founder | 67 | 12-02-20 |
Founder | 60 | 12-02-20 | |
Alison Lawton
BRD | Director/Board Member | 62 | 14-09-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.95 | +6.56% | 64,672 |
24-05-30 | 1.83 | -.--% | 162,934 |
24-05-29 | 1.83 | -0.54% | 90,679 |
24-05-28 | 1.84 | -2.13% | 113,019 |
24-05-24 | 1.88 | -0.53% | 70,262 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.52% | 159M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- PRQR Stock